The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Leukemia Treatment Drugs Market Research Report 2025

Global Leukemia Treatment Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1713715

No of Pages : 82

Ask Your Query

Synopsis

Market Analysis and Insights: Global Leukemia Treatment Drugs Market

Leukemia Treatment Drugs is used to cure Leukemia.

The global Leukemia Treatment Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Leukemia Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Leukemia Treatment Drugs market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Leukemia Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Leukemia Treatment Drugs market.

Global Leukemia Treatment Drugs Scope and Market Size
Leukemia Treatment Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Leukemia Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Gleevec
  • Sapacitabine
  • GA101
  • Vasaroxine
  • Tosedosat
  • Revlimid
  • Bosutinib

Segment by Application

  • Hospitals
  • Research Institutes
  • Diagnostic Centers
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Gsk
  • Pfizer
  • Novartis Ag
  • Roche
  • Celgene
  • Biogen
  • Genzyme Corporation
  • Eisai C.
  • Bristol Myers Squibb Company (Bms)
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukemia Treatment Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Gleevec
1.2.3 Sapacitabine
1.2.4 GA101
1.2.5 Vasaroxine
1.2.6 Tosedosat
1.2.7 Revlimid
1.2.8 Bosutinib
1.3 Market by Application
1.3.1 Global Leukemia Treatment Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Research Institutes
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Leukemia Treatment Drugs Market Perspective (2017-2028)
2.2 Leukemia Treatment Drugs Growth Trends by Region
2.2.1 Leukemia Treatment Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Leukemia Treatment Drugs Historic Market Size by Region (2017-2022)
2.2.3 Leukemia Treatment Drugs Forecasted Market Size by Region (2023-2028)
2.3 Leukemia Treatment Drugs Market Dynamics
2.3.1 Leukemia Treatment Drugs Industry Trends
2.3.2 Leukemia Treatment Drugs Market Drivers
2.3.3 Leukemia Treatment Drugs Market Challenges
2.3.4 Leukemia Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Leukemia Treatment Drugs Players by Revenue
3.1.1 Global Top Leukemia Treatment Drugs Players by Revenue (2017-2022)
3.1.2 Global Leukemia Treatment Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Leukemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Leukemia Treatment Drugs Revenue
3.4 Global Leukemia Treatment Drugs Market Concentration Ratio
3.4.1 Global Leukemia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukemia Treatment Drugs Revenue in 2021
3.5 Leukemia Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Leukemia Treatment Drugs Product Solution and Service
3.7 Date of Enter into Leukemia Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Leukemia Treatment Drugs Breakdown Data by Type
4.1 Global Leukemia Treatment Drugs Historic Market Size by Type (2017-2022)
4.2 Global Leukemia Treatment Drugs Forecasted Market Size by Type (2023-2028)
5 Leukemia Treatment Drugs Breakdown Data by Application
5.1 Global Leukemia Treatment Drugs Historic Market Size by Application (2017-2022)
5.2 Global Leukemia Treatment Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Leukemia Treatment Drugs Market Size (2017-2028)
6.2 North America Leukemia Treatment Drugs Market Size by Country (2017-2022)
6.3 North America Leukemia Treatment Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Leukemia Treatment Drugs Market Size (2017-2028)
7.2 Europe Leukemia Treatment Drugs Market Size by Country (2017-2022)
7.3 Europe Leukemia Treatment Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Leukemia Treatment Drugs Market Size (2017-2028)
8.2 Asia-Pacific Leukemia Treatment Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Leukemia Treatment Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Leukemia Treatment Drugs Market Size (2017-2028)
9.2 Latin America Leukemia Treatment Drugs Market Size by Country (2017-2022)
9.3 Latin America Leukemia Treatment Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Leukemia Treatment Drugs Market Size (2017-2028)
10.2 Middle East & Africa Leukemia Treatment Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Leukemia Treatment Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Leukemia Treatment Drugs Introduction
11.1.4 GSK Revenue in Leukemia Treatment Drugs Business (2017-2022)
11.1.5 GSK Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Leukemia Treatment Drugs Introduction
11.2.4 Pfizer Revenue in Leukemia Treatment Drugs Business (2017-2022)
11.2.5 Pfizer Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Detail
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Leukemia Treatment Drugs Introduction
11.3.4 Novartis AG Revenue in Leukemia Treatment Drugs Business (2017-2022)
11.3.5 Novartis AG Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Leukemia Treatment Drugs Introduction
11.4.4 Roche Revenue in Leukemia Treatment Drugs Business (2017-2022)
11.4.5 Roche Recent Development
11.5 Celgene
11.5.1 Celgene Company Detail
11.5.2 Celgene Business Overview
11.5.3 Celgene Leukemia Treatment Drugs Introduction
11.5.4 Celgene Revenue in Leukemia Treatment Drugs Business (2017-2022)
11.5.5 Celgene Recent Development
11.6 Biogen
11.6.1 Biogen Company Detail
11.6.2 Biogen Business Overview
11.6.3 Biogen Leukemia Treatment Drugs Introduction
11.6.4 Biogen Revenue in Leukemia Treatment Drugs Business (2017-2022)
11.6.5 Biogen Recent Development
11.7 Genzyme Corporation
11.7.1 Genzyme Corporation Company Detail
11.7.2 Genzyme Corporation Business Overview
11.7.3 Genzyme Corporation Leukemia Treatment Drugs Introduction
11.7.4 Genzyme Corporation Revenue in Leukemia Treatment Drugs Business (2017-2022)
11.7.5 Genzyme Corporation Recent Development
11.8 Eisai C.
11.8.1 Eisai C. Company Detail
11.8.2 Eisai C. Business Overview
11.8.3 Eisai C. Leukemia Treatment Drugs Introduction
11.8.4 Eisai C. Revenue in Leukemia Treatment Drugs Business (2017-2022)
11.8.5 Eisai C. Recent Development
11.9 Bristol Myers Squibb Company (BMS)
11.9.1 Bristol Myers Squibb Company (BMS) Company Detail
11.9.2 Bristol Myers Squibb Company (BMS) Business Overview
11.9.3 Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Introduction
11.9.4 Bristol Myers Squibb Company (BMS) Revenue in Leukemia Treatment Drugs Business (2017-2022)
11.9.5 Bristol Myers Squibb Company (BMS) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Leukemia Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Gleevec
Table 3. Key Players of Sapacitabine
Table 4. Key Players of GA101
Table 5. Key Players of Vasaroxine
Table 6. Key Players of Tosedosat
Table 7. Key Players of Revlimid
Table 8. Key Players of Bosutinib
Table 9. Global Leukemia Treatment Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Leukemia Treatment Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Leukemia Treatment Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Leukemia Treatment Drugs Market Share by Region (2017-2022)
Table 13. Global Leukemia Treatment Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Leukemia Treatment Drugs Market Share by Region (2023-2028)
Table 15. Leukemia Treatment Drugs Market Trends
Table 16. Leukemia Treatment Drugs Market Drivers
Table 17. Leukemia Treatment Drugs Market Challenges
Table 18. Leukemia Treatment Drugs Market Restraints
Table 19. Global Leukemia Treatment Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Leukemia Treatment Drugs Market Share by Players (2017-2022)
Table 21. Global Top Leukemia Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Treatment Drugs as of 2021)
Table 22. Ranking of Global Top Leukemia Treatment Drugs Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Leukemia Treatment Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Leukemia Treatment Drugs Product Solution and Service
Table 26. Date of Enter into Leukemia Treatment Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Leukemia Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Leukemia Treatment Drugs Revenue Market Share by Type (2017-2022)
Table 30. Global Leukemia Treatment Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Leukemia Treatment Drugs Revenue Market Share by Type (2023-2028)
Table 32. Global Leukemia Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Leukemia Treatment Drugs Revenue Market Share by Application (2017-2022)
Table 34. Global Leukemia Treatment Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Leukemia Treatment Drugs Revenue Market Share by Application (2023-2028)
Table 36. North America Leukemia Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Leukemia Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Leukemia Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 39. Europe Leukemia Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 40. Asia-Pacific Leukemia Treatment Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 41. Asia-Pacific Leukemia Treatment Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 42. Latin America Leukemia Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 43. Latin America Leukemia Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 44. Middle East & Africa Leukemia Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 45. Middle East & Africa Leukemia Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 46. GSK Company Detail
Table 47. GSK Business Overview
Table 48. GSK Leukemia Treatment Drugs Product
Table 49. GSK Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
Table 50. GSK Recent Development
Table 51. Pfizer Company Detail
Table 52. Pfizer Business Overview
Table 53. Pfizer Leukemia Treatment Drugs Product
Table 54. Pfizer Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Novartis AG Company Detail
Table 57. Novartis AG Business Overview
Table 58. Novartis AG Leukemia Treatment Drugs Product
Table 59. Novartis AG Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
Table 60. Novartis AG Recent Development
Table 61. Roche Company Detail
Table 62. Roche Business Overview
Table 63. Roche Leukemia Treatment Drugs Product
Table 64. Roche Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Celgene Company Detail
Table 67. Celgene Business Overview
Table 68. Celgene Leukemia Treatment Drugs Product
Table 69. Celgene Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
Table 70. Celgene Recent Development
Table 71. Biogen Company Detail
Table 72. Biogen Business Overview
Table 73. Biogen Leukemia Treatment Drugs Product
Table 74. Biogen Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
Table 75. Biogen Recent Development
Table 76. Genzyme Corporation Company Detail
Table 77. Genzyme Corporation Business Overview
Table 78. Genzyme Corporation Leukemia Treatment Drugs Product
Table 79. Genzyme Corporation Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
Table 80. Genzyme Corporation Recent Development
Table 81. Eisai C. Company Detail
Table 82. Eisai C. Business Overview
Table 83. Eisai C. Leukemia Treatment Drugs Product
Table 84. Eisai C. Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
Table 85. Eisai C. Recent Development
Table 86. Bristol Myers Squibb Company (BMS) Company Detail
Table 87. Bristol Myers Squibb Company (BMS) Business Overview
Table 88. Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Product
Table 89. Bristol Myers Squibb Company (BMS) Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
Table 90. Bristol Myers Squibb Company (BMS) Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leukemia Treatment Drugs Market Share by Type: 2021 VS 2028
Figure 2. Gleevec Features
Figure 3. Sapacitabine Features
Figure 4. GA101 Features
Figure 5. Vasaroxine Features
Figure 6. Tosedosat Features
Figure 7. Revlimid Features
Figure 8. Bosutinib Features
Figure 9. Global Leukemia Treatment Drugs Market Share by Application in 2021 & 2028
Figure 10. Hospitals Case Studies
Figure 11. Research Institutes Case Studies
Figure 12. Diagnostic Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Leukemia Treatment Drugs Report Years Considered
Figure 15. Global Leukemia Treatment Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Leukemia Treatment Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Leukemia Treatment Drugs Market Share by Region: 2021 VS 2028
Figure 18. Global Leukemia Treatment Drugs Market Share by Players in 2021
Figure 19. Global Top Leukemia Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Treatment Drugs as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Leukemia Treatment Drugs Revenue in 2021
Figure 21. North America Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. North America Leukemia Treatment Drugs Market Share by Country (2017-2028)
Figure 23. United States Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Leukemia Treatment Drugs Market Share by Country (2017-2028)
Figure 27. Germany Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Leukemia Treatment Drugs Market Share by Region (2017-2028)
Figure 35. China Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Leukemia Treatment Drugs Market Share by Country (2017-2028)
Figure 43. Mexico Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Brazil Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Leukemia Treatment Drugs Market Share by Country (2017-2028)
Figure 47. Turkey Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Saudi Arabia Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. GSK Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
Figure 50. Pfizer Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
Figure 51. Novartis AG Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
Figure 52. Roche Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
Figure 53. Celgene Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
Figure 54. Biogen Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
Figure 55. Genzyme Corporation Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
Figure 56. Eisai C. Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
Figure 57. Bristol Myers Squibb Company (BMS) Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock